Reseña del editor
The most meaningful reward to clinicians and researchers is the absence of recurrent malignancy in their patients. While in some patients the disease will be cured by resection alone, in other similarly staged cases the disease will recur despite adequate loco regional and systemic therapies. Hence, risk assessment is a complex issue with many related or unrelated prognostic factors determining outcome. The purpose of this volume is to review some of the most relevant prognostic factors of newly diagnosed breast cancer, focusing on fea tures determining the magnitude of risk. The ultimate value of establishing the significance of each prognostic factor in a given patient will be the resulting ability to plan individu alized therapies for patients at different risk of recurrence at the time of diagnosis. To secure the maximum benefit for high-risk patients, while avoiding undue toxicity in those with low-risk lesions, a well-integrated analysis of all known prognostic factors will be essential in the early postdiagnos tic period. In addition to well-established staging criteria such as axillary nodes, tumor size, receptors, scanning and radiographic examinations, the more sophisticated labora tory techniques, as discussed by several authors herein, will playa crucial role in risk assessment. Most of them, - ploidy determination, oncogenes, tumor markers, monoclonal anti bodies, growth factors, etc. -are presently available in only a minority of treatment centers.
Reseña del editor
This overview of diagnostic aspects of breast cancer focuses on high-risk features and risk determinants of newly disease. It offers a unique update enabling the quantification of the risk at diagnosis. This book differs from others on breast cancer by its focus on risk, and by providing a comprehensive summary of modern diagnostic approaches to the disease. Individual chapters provide not only an update on more conventional diagnostic techniques such as those derived from epidemiology, mammography, pathology and hormone receptors, but also insight into the newest aspects of modern technological approaches, including kinetic determinations with the help of flow cytometry, labeling index, oncogenic assessment, immunology, chromosomal assessment and in vitro cultures. There is increasing evidence that a refined analysis of all risk factors will offer clinicians valuable information on the type and degree of disease aggressiveness in a given patient. Such information will be essential in deciding the individual therapeutic strategy so as to avoid overtreating low risk individuals and undertreating high-risk cases. Correct determination of the risk at diagnosis will likely lead the way to an increase in cure rates and to improvement of the overall cost-benefit ratio of breast cancer treatment.
"Sobre este título" puede pertenecer a otra edición de este libro.
Otras ediciones populares con el mismo título
Resultados de la búsqueda para High-Risk Breast Cancer: Diagnosis
Imagen del vendedor
High-Risk Breast Cancer: Diagnosis
Publicado por
Springer, 1989
ISBN 10: 3540192921
ISBN 13: 9783540192923
Antiguo o usado
Tapa dura
Original o primera edición
Librería: Bookshop Baltimore, Baltimore, MD, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Hardcover. Condición: VG. First Edition. With 67 Figures and 40 Tables. 383 pages. Near fine to very good condition, no name inside. Light board wear - there is a light edge bump on the upper top and bottom edge. Includes essays by various experts on Epidemiology, Oncogense, Flow Cytometry, Tumor Kinetics, Receptors, Pathology, Mammography, Immunology, etc. Nº de ref. del artículo: 18157
Comprar usado
EUR 19,51
Envío por EUR 5,17
Se envía dentro de Estados Unidos de America
Se envía dentro de Estados Unidos de America
Cantidad disponible: 1 disponibles